Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

• Status: Unknown status
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether application of low dose Delta9-Tetrahydrocannabinol can prevent the development of chronic pain in patients with acute CRPS.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ludwig-Maximilians - University of Munich
• Collaborators: German Federal Ministry of Education and Research; German Research Network on Neuropathic Pain
• Treatments: Dronabinol

Criteria

Inclusion Criteria:

• Patients with clinical diagnosis of acute CRPS (time from inciting event less than 16 weeks) of the upper extremity

• No risk of dependency in a psychological assessment

Exclusion Criteria:

• History of alcohol or drug abuse

• Cardiac arrhythmias

• Acute or chronic renal failure

• ASA physical status classification III or higher

• Psychiatric disorders

• Pregnancy and breast feeding